Abdelkawi Salwa Ahmed, Hassan Aziza Ahmed, Ghoneim Dina Fouad, Sayed Saif Ahmed Tamer
Department of Vision Science, Biophysics and Laser Science Unit, Research Institute of Ophthalmology, Giza, Egypt.
Ophthalmic Unit, National Institute for Laser Enhanced Science, Cairo University, Egypt.
J Lasers Med Sci. 2019 Winter;10(1):50-55. doi: 10.15171/jlms.2019.08. Epub 2018 Dec 15.
The efficacy of many therapeutics techniques for treatment of branch retinal vein occlusion (BRVO) has been the subject of many investigations. The aim of the present work is to evaluate the transluminal Nd: YAG laser thrombolysis as a new therapeutic approach used for treatment of BRVO in rabbits as an experimental model. Four rabbits were considered as a control (n=8 eyes); occlusion of the branch retinal veins was performed by using a dye enhancing thrombus formation in right eyes of 10 rabbits (n=10 eyes). Thrombi in the retinal veins were induced by intravenous injection of rose bengal solution as a photosensitizer immediately before the argon laser application with a power of 1200 mW, a spot size of 100 µm, and a duration of 20 ms. One week later, transluminal Nd: YAG laser thrombolysis (30 mJ, 3 pulses/4 ns) was employed to the site of occluded veins, until the thrombi were partially or completely shattered. The rabbits were followed up after 4 days, 1 week and 2 weeks for slit lamp fundus examination and the treated retinas were isolated for histopathological examination. Argon laser photothrombosis induced complete BRVO with some vitreous hemorrhage, destruction, and necrosis in the surrounding retinal layers. Moreover, one week later, Nd: YAG laser thrombolysis showed complete venous flow, minimal vitreous hemorrhage, reperfused retina, complete veins improvement. Follow up after 2 weeks revealed more improvement of all retinal layers. Treatment with transluminal Nd: YAG laser thrombolysis represented a novel therapeutic modality in BRVO.
许多治疗视网膜分支静脉阻塞(BRVO)的治疗技术的疗效已成为众多研究的主题。本研究的目的是评估腔内Nd:YAG激光溶栓作为一种用于治疗兔BRVO的新治疗方法的效果,以兔作为实验模型。4只兔子作为对照组(n = 8只眼);通过在10只兔子的右眼使用增强血栓形成的染料来阻塞视网膜分支静脉(n = 10只眼)。在应用功率为1200 mW、光斑大小为100 µm、持续时间为20 ms的氩激光之前,立即静脉注射孟加拉玫瑰红溶液作为光敏剂,以诱导视网膜静脉血栓形成。一周后,对阻塞静脉部位采用腔内Nd:YAG激光溶栓(30 mJ,3脉冲/4 ns),直到血栓部分或完全破碎。在4天、1周和2周后对兔子进行随访,进行裂隙灯眼底检查,并分离治疗后的视网膜进行组织病理学检查。氩激光光凝血栓形成诱导了完全性BRVO,并伴有一些玻璃体出血、周围视网膜层的破坏和坏死。此外,一周后,Nd:YAG激光溶栓显示静脉血流完全恢复、玻璃体出血极少、视网膜再灌注、静脉完全改善。2周后的随访显示所有视网膜层有更多改善。腔内Nd:YAG激光溶栓治疗是BRVO的一种新型治疗方式。